Noveome Biotherapeutics INC
Regenerative medicine company
Based in PA
AI Overview
With $280K in lobbying spend across 13 quarterly filings, Noveome Biotherapeutics INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $90K |
| 2019 | $90K |
| 2020 | $90K |
| 2021 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Noveome Biotherapeutics INC disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
Medical research and development issues, as follows:
H.R.3219, Department of Defense Appropriations Act, FY2018
Department of Defense Appropriations Act, FY2019
Public Law 115-141, Consolidated App
Medical research and development issues, as follows:
H.R.6157, Department of Defense Appropriations Act, FY2019
Public Law 115-141, Consolidated Appropriations Act, FY2018
Medical research and development issues, as follows:
H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019
Public Law 115-141, Consolidated A
Monitor Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Medical research and development issues
Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Implementation of Medical research and development issues
Department of Defen
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.